Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Respiratory infections: clinical evaluation.

C Grassi

    Clinical Therapeutics
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Piperacillin effectively treats respiratory infections caused by various bacteria, including gram-negative and anaerobic organisms. Clinical studies show high cure rates and good tolerability, making it a valuable antibiotic option.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Ventral striatal neuroimmune signalling biases the expression of social memory in male mice.

    Brain, behavior, and immunity·2026
    Same author

    HSV-1 infection induces phosphorylated tau propagation among neurons via extracellular vesicles.

    mBio·2024
    Same author

    Combined molecular and mathematical analysis of long noncoding RNAs expression in fine needle aspiration biopsies as novel tool for early diagnosis of thyroid cancer.

    Endocrine·2020
    Same author

    Neural functional correlates of emotional processing in patients with first-episode psychoses: an activation likelihood estimation (ALE) meta-analysis.

    Archives italiennes de biologie·2018
    Same author

    Styrene enhances the noise induced oxidative stress in the cochlea and affects differently mechanosensory and supporting cells.

    Free radical biology & medicine·2016
    Same author

    Extracellular Tau Oligomers Produce An Immediate Impairment of LTP and Memory.

    Scientific reports·2016
    Same journal

    Early Feasibility Studies in Europe: A Multisite Qualitative Study of Operational Challenges and Site Selection Determinants at 6 University Hospitals.

    Clinical therapeutics·2026
    Same journal

    Safety of Celecoxib in Elderly Patients With Osteoarthritis: A Real-World Analysis Based on the FAERS Database.

    Clinical therapeutics·2026
    Same journal

    Reimagining Representation Across the Clinical Research Ecosystem: Part II of a Specialty Update on Advancing Diversity, Racial Equity, and Inclusion in Clinical Research.

    Clinical therapeutics·2026
    Same journal

    Combined Effects of Nicorandil and Enhanced External Counterpulsation on Coronary Microcirculation and Exercise Capacity in Patients With Coronary Slow Flow Phenomenon: A Randomized, Controlled, 3-Arm Trial.

    Clinical therapeutics·2026
    Same journal

    Phase 1 Study Evaluating Gefurulimab Pharmacokinetics and Safety Following Delivery Via Autoinjector or Prefilled Syringe With Needle Safety Device in Healthy Adults.

    Clinical therapeutics·2026
    Same journal

    Evaluating Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Associated With Newer Antiseizure Medications Using FAERS and JADER Combined With Bioinformatics Exploration.

    Clinical therapeutics·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Infectious Diseases
    • Clinical Microbiology

    Background:

    • Piperacillin is a broad-spectrum penicillin antibiotic.
    • Respiratory tract infections (RTIs) pose a significant clinical challenge.
    • Enterobacteriaceae, Pseudomonas sp., anaerobes, and mixed flora are common RTI pathogens.

    Purpose of the Study:

    • To review the efficacy of piperacillin in treating respiratory infections.
    • To evaluate piperacillin's effectiveness against specific bacterial pathogens.
    • To compare piperacillin's efficacy with combination antibiotic therapies.

    Main Methods:

    • Review of clinical studies involving piperacillin treatment for RTIs.
    • Analysis of patient outcomes, including cure rates and clinical improvement.

    Related Experiment Videos

  • Examination of bacteriological eradication rates of susceptible strains.

    • Main Results:

    • 97% of 420 patients with lower RTIs showed cure or marked improvement.
    • Piperacillin demonstrated efficacy comparable to combination therapies for serious infections.
    • 82% (126/153) of susceptible bacterial strains were eradicated.
    • Complete eradication achieved against Streptococcus pneumoniae, beta-hemolytic streptococci, Haemophilus influenzae, Peptostreptococcus sp., Bacteroides sp., and Fusobacterium sp.

    Conclusions:

    • Piperacillin is a valuable therapeutic option for respiratory infections.
    • The antibiotic is effective against a wide range of pathogens, including gram-negative and anaerobic organisms.
    • Piperacillin therapy is generally well-tolerated and comparable to combination regimens.